← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
  1. Home
  2. GEHC
  3. P/E History
OverviewAnalysisPriceRevenueEarningsP/ERatiosDividendTargets

GEHC logoGE HealthCare Technologies Inc. (GEHC) P/E Ratio History

Historical price-to-earnings valuation from 2022 to 2026

Current P/E
13.5
Undervalued
5Y Avg P/E
20.7
-35% vs avg
PE Percentile
7%
Low
PEG Ratio
N/A
N/A
TTM EPS$3.29
Price$61.34
5Y PE Range12.6 - 26.6
Earnings Yield7.42%

Loading P/E history...

GEHC Valuation Context

How does the current P/E compare to historical and market benchmarks?

vs. 5Y Average
13.5vs20.7
-35%
Cheap vs History
vs. Healthcare
13.5vs22.3
-40%
Below Sector
vs. S&P 500
13.5vs25.1
-46%
Below Market
PEG Analysis
N/A
P/E ÷ EPS Growth
Based on 5% EPS growth (1Y)
Export Data

P/E Ratio Analysis

As of May 8, 2026, GE HealthCare Technologies Inc. (GEHC) trades at a price-to-earnings ratio of 13.5x, with a stock price of $61.34 and trailing twelve-month earnings per share of $3.29.

The current P/E is 35% below its 5-year average of 20.7x. Over the past five years, GEHC's P/E has ranged from a low of 12.6x to a high of 26.6x, placing the current valuation at the 7th percentile of its historical range.

Compared to the Healthcare sector median P/E of 22.3x, GEHC trades at a 40% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.

Relative to the broader market, GEHC trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our GEHC DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

GEHC P/E vs Peers

P/E ratio compared to closely matched public peers

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
SYK logoSYKStryker Corporation
$113B35.02.36+8%
BSX logoBSXBoston Scientific Corporation
$84B29.2-+55%
EW logoEWEdwards Lifesciences Corporation
$48B45.26.39-74%
PHG logoPHGKoninklijke Philips N.V.
$26B24.9-+224%Best
HOLX logoHOLXHologic, Inc.
$17B30.5--25%
MDT logoMDTMedtronic plc
$100B21.6-+31%
ABT logoABTAbbott Laboratories
$151B11.4Lowest0.38Best+134%
ISRG logoISRGIntuitive Surgical, Inc.
$161B57.62.65+23%
NVST logoNVSTEnvista Holdings Corp
$4B86.758.08+104%

Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.

GEHC Historical P/E Data (2022–2026)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterDatePriceTTM EPSP/E Ratiovs Avg
FY2026 Q1$71.18$3.2721.8x+5%
FY2025 Q4Wed Dec 31 2025 00:00:00 GM$82.02$3.6522.5x+9%
FY2025 Q3$75.10$4.8415.5x-25%
FY2025 Q2Mon Jun 30 2025 00:00:00 GM$74.07$4.8815.2x-27%
FY2025 Q1Mon Mar 31 2025 00:00:00 GM$80.71$4.7517.0x-18%
FY2024 Q4$78.18$4.3318.1x-13%
FY2024 Q3Mon Sep 30 2024 00:00:00 GM$93.85$3.6425.8x+25%
FY2024 Q2Sun Jun 30 2024 00:00:00 GM$77.92$3.4422.7x+10%
FY2024 Q1Sun Mar 31 2024 00:00:00 GM$90.91$3.4226.6x+29%
FY2023 Q4Sun Dec 31 2023 00:00:00 GM$77.32$3.0225.6x+24%
FY2023 Q3Sat Sep 30 2023 00:00:00 GM$68.04$3.3620.3x-2%
FY2023 Q2Fri Jun 30 2023 00:00:00 GM$81.24$3.4023.9x+16%

Average P/E for displayed period: 20.7x

Full GEHC Stock Analysis

Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.

View Analysis

See GEHC's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is GEHC Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare GEHC vs DBVT

Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..

Start Comparison

GEHC — Frequently Asked Questions

Quick answers to the most common questions about buying GEHC stock.

Is GEHC stock overvalued or undervalued?

GEHC trades at 13.5x P/E, below its 5-year average of 20.7x. At the 7th percentile of historical range, the stock is priced at a discount to its own history.

How does GEHC's valuation compare to peers?

GE HealthCare Technologies Inc. P/E of 13.5x compares to sector median of 22.3x. The discount suggests lower growth expectations or higher risk.

What is GEHC's PEG ratio?

GEHC PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2022-2026.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.

GEHC P/E Ratio History (2022–2026)

P/E ratio calculated as closing price divided by trailing 12-month diluted EPS at each quarter end.